Ionis Pharmaceuticals, Inc. (IONS)

NASDAQ: IONS · Real-Time Price · USD

54.04

-1.26 (-2.28%)

At close: Jul 29, 2026, 4:00 PM EDT

54.04

0.00 (0.00%)

After-hours: Jul 29, 2026, 7:59 PM EDT

Ionis Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	874.09	943.71	705.14	787.65	587.37	810.46
Revenue Growth	-7.41%	33.83%	-10.47%	34.10%	-27.53%	11.13%
Cost of Revenue	16.02	15.91	11.22	9.13	14.12	10.84
Gross Profit	858.07	927.8	693.92	778.51	573.25	799.61
Selling, General & Admin	527.75	393.87	267.47	232.62	150.3	186.35
Research & Development	924.68	915.62	901.53	899.63	833.15	643.45
Total Operating Expenses	1,452	1,309	1,169	1,132	983.44	829.8
Operating Income	-102.29	-381.68	-475.08	-353.73	-410.19	-30.19
Interest Income	94.13	97.77	107.02	89.04	25.33	10.04
Interest Expense	-89.47	-90.54	-90.45	-81.46	-8.12	-9.35
Other Non-Operating Income (Expense)	19.73	-5.14	-1.56	12.18	135	0.34
Total Non-Operating Income (Expense)	24.38	2.08	15.01	19.77	152.21	1.04
Pretax Income	-205.69	-379.6	-460.07	-333.97	-257.99	-29.15
Provision for Income Taxes	0.22	1.79	-6.17	32.32	11.74	-0.55
Net Income	-114.65	-381.39	-453.9	-366.29	-269.72	-28.6
Net Income to Common	-114.65	-381.39	-453.9	-366.29	-269.72	-28.6
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	163	160	150	143	142	141
Shares Outstanding (Diluted)	163	160	150	143	142	141
Shares Change	0.68%	7.02%	4.42%	0.95%	0.59%	1.01%
EPS (Basic)	-3.46	-2.38	-3.04	-2.56	-1.90	-0.20
EPS (Diluted)	-3.46	-2.38	-3.04	-2.56	-1.90	-0.20
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-560.84	-320.03	-546.23	-331.32	-290.09	18.84
Free Cash Flow Growth	-	-	-	-	-	2340.93%
Free Cash Flow Per Share	-3.44	-2.00	-3.65	-2.31	-2.05	0.13
Gross Margin	98.17%	98.31%	98.41%	98.84%	97.60%	98.66%
Operating Margin	-11.70%	-40.45%	-67.37%	-44.91%	-69.84%	-3.72%
Profit Margin	-13.12%	-40.41%	-64.37%	-46.50%	-45.92%	-3.53%
FCF Margin	-64.16%	-33.91%	-77.46%	-42.06%	-49.39%	2.33%
EBITDA	-75.37	-358.99	-453.09	-331.23	-388.09	-10.63
EBITDA Margin	-8.62%	-38.04%	-64.26%	-42.05%	-66.07%	-1.31%
EBIT	-102.29	-381.68	-475.08	-353.73	-410.19	-30.19
EBIT Margin	-11.70%	-40.45%	-67.37%	-44.91%	-69.84%	-3.72%
Effective Tax Rate	-0.11%	-0.47%	1.34%	-9.68%	-4.55%	1.89%

SEC Filings: 10-K · 10-Q